AU
ROIV icon

AlphaGrep UK’s Roivant Sciences ROIV Stock Holding History

AlphaGrep UK’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Sell
12,745
-19,126
-60% -$565K 0.13% 274
2026
Q1 		$883K Buy
31,871
+12,934
+68% +$332K 0.26% 42
2025
Q4 		$411K Buy
+18,937
New +$374K 0.14% 275

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK's ROIV Position: Q2 2026 in Review

AlphaGrep UK reduced its Roivant Sciences (ROIV) stake by 60% in Q2 2026, selling an estimated $565K and leaving 12,745 shares worth $451K. The position accounts for 0.13% of the portfolio, ranked #274.

AlphaGrep UK first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. The position peaked at $883K in Q1 2026. 464 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • AlphaGrep UK held 12,745 shares of Roivant Sciences worth $451K as of Q2 2026.
  • AlphaGrep UK sold 19,126 Roivant Sciences shares in Q2 2026, an estimated $565K.
  • Roivant Sciences made up 0.13% of AlphaGrep UK's portfolio in Q2 2026, its #274 holding.
  • AlphaGrep UK first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Roivant Sciences position peaked at $883K in Q1 2026.
  • 464 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.